We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for zongertinib (Boehringer Ingelheim Pty Ltd)
Active ingredients
zongertinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology